Calcitriol

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instanceOf hormone
vitamin D metabolite
gptkbp:ATCCode A11CC04
gptkbp:bioavailability high
gptkbp:CASNumber 32222-06-3
gptkbp:chemicalFormula C27H44O3
gptkbp:contraindication gptkb:hypercalcemia
vitamin D toxicity
gptkbp:discoveredIn 1971
gptkbp:eliminationHalfLife 5-8 hours
gptkbp:excretion urine
gptkbp:foundIn humans
other vertebrates
https://www.w3.org/2000/01/rdf-schema#label Calcitriol
gptkbp:increasesAbsorptionOf calcium
phosphate
gptkbp:inhibitedBy parathyroid hormone secretion
gptkbp:IUPACName (1R,3S,5Z,7E,22E)-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,25-triol
gptkbp:KEGGID D00279
gptkbp:legalStatus prescription only
gptkbp:meltingPoint 120 °C
gptkbp:MeSH_ID D017382
gptkbp:metabolism liver
gptkbp:molecularWeight 416.64 g/mol
gptkbp:otherName gptkb:1,25-dihydroxyvitamin_D3
gptkb:Rocaltrol
gptkb:Calcijex
1,25(OH)2D3
gptkbp:predecessor gptkb:25-hydroxyvitamin_D3
gptkbp:pregnancyCategory C (US)
gptkbp:producedBy gptkb:kidney
gptkbp:PubChem_CID 5280453
CHEMBL1204
DB00136
gptkbp:recipient vitamin D receptor
gptkbp:regulates calcium homeostasis
phosphate homeostasis
gptkbp:routeOfAdministration oral
topical
intravenous
gptkbp:sideEffect gptkb:hypercalcemia
nausea
vomiting
headache
weakness
hyperphosphatemia
gptkbp:UNII FXC9231JVH
gptkbp:usedFor gptkb:bone
gptkb:secondary_hyperparathyroidism
psoriasis
chronic kidney disease
hypocalcemia
gptkbp:bfsParent gptkb:Cholesterol
gptkb:Kidneys
gptkbp:bfsLayer 6